SPONSOR
Washington University School of Medicine
Total Trials
3
Recruiting
3
Phases
Phase 1
Washington University School of Medicine is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Multiple Myeloma, Chronic Pain, Depression, Anxiety, Alzheimer Disease.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Washington University School of Medicine
How many clinical trials has Washington University School of Medicine sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Washington University School of Medicine, of which 3 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, Chronic Pain, Depression, Anxiety. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Washington University School of Medicine research focus on?
Washington University School of Medicine clinical trials span Multiple Myeloma, Chronic Pain, Depression, Anxiety, Alzheimer Disease. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Washington University School of Medicine clinical trial?
To participate in a Washington University School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Washington University School of Medicine trials with current recruitment status updated daily.
Clinical Trials by Washington University School of Medicine
NCT06623630 Phase 1
Recruiting
Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Multiple Myeloma
NCT06978166
Recruiting
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
Chronic Pain
NCT06439992
Recruiting
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl
Alzheimer Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology